Zoetis Inc. Quarterly Report for Q1 Ended Mar 31, 2020

Summary

Zoetis Inc. reported solid financial results for the first quarter of 2020, demonstrating resilience amid early signs of the COVID-19 pandemic's impact. The company saw a 5% increase in total revenue to $1.534 billion, driven by a 7% operational increase, excluding foreign exchange fluctuations. This growth was fueled by price increases, contributions from new and existing products, and recent acquisitions. Profitability also improved significantly, with net income rising 36% year-over-year to $423 million, resulting in diluted earnings per share of $0.88, up from $0.65 in the prior year. This strong performance was supported by a notable improvement in the cost of sales as a percentage of revenue, which decreased from 35.6% to 29.9%, largely due to a favorable inventory costing estimate change in the prior year and price increases. While the company acknowledges the evolving uncertainties posed by COVID-19, particularly for the second quarter, the first quarter results indicate a strong operational foundation.

Key Highlights

• 1Total revenue increased by 5% to $1.534 billion, with a 7% operational increase excluding foreign exchange.
• 2Net income surged by 36% to $423 million, leading to a diluted EPS of $0.88, up from $0.65 in Q1 2019.
• 3Cost of sales as a percentage of revenue improved significantly, decreasing from 35.6% to 29.9%.
• 4Selling, general, and administrative expenses increased by 5% to $389 million, in line with revenue growth and acquisitions.
• 5Research and development expenses grew by 5% to $107 million, reflecting ongoing investment in innovation.
• 6The company ended the quarter with a strong cash position of $1.951 billion.
• 7Zoetis reported a 9% revenue increase in its U.S. segment, driven by companion animal products, while its International segment saw a 1% increase.

Frequently Asked Questions